Next Article in Journal
Ethnicity and Breast Cancer Stage at Diagnosis: An Issue of Health Equity
Previous Article in Journal
Canadian Cancer Screening Disparities: A Recent Historical Perspective
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 22
Issue 2
10.3747/co.22.2579
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

The Value-for-Money of Adjuvant Aromatase Inhibitors: Time to Put the Debate to Rest?

by
T. Younis
* and
A. Groom
Dalhousie University, Department of Medicine, QE II Health Sciences Centre, Halifax, NS, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2015, 22(2), 77-79; https://doi.org/10.3747/co.22.2579
Submission received: 2 January 2015 / Revised: 12 February 2015 / Accepted: 9 March 2015 / Published: 1 April 2015

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The adoption of costly treatments in public health care systems, such as exists in Canada, must take into account their “clinical benefit to side effect” profiles and “value for money” in an attempt to maximize health gains within current budget constraints [...]

Share and Cite

MDPI and ACS Style

Younis, T.; Groom, A. The Value-for-Money of Adjuvant Aromatase Inhibitors: Time to Put the Debate to Rest? Curr. Oncol. 2015, 22, 77-79. https://doi.org/10.3747/co.22.2579

AMA Style

Younis T, Groom A. The Value-for-Money of Adjuvant Aromatase Inhibitors: Time to Put the Debate to Rest? Current Oncology. 2015; 22(2):77-79. https://doi.org/10.3747/co.22.2579

Chicago/Turabian Style

Younis, T., and A. Groom. 2015. "The Value-for-Money of Adjuvant Aromatase Inhibitors: Time to Put the Debate to Rest?" Current Oncology 22, no. 2: 77-79. https://doi.org/10.3747/co.22.2579

APA Style

Younis, T., & Groom, A. (2015). The Value-for-Money of Adjuvant Aromatase Inhibitors: Time to Put the Debate to Rest? Current Oncology, 22(2), 77-79. https://doi.org/10.3747/co.22.2579

Article Metrics

Back to TopTop